Aarti Drugs promoter group encumbers 12.39 lakh shares

3 min read     Updated on 07 Jul 2026, 05:44 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Aarti Drugs Limited disclosed that two members of its promoter group have encumbered a total of 12,39,771 shares as on March 31, 2026. The filing was submitted by Harshit M. Savla, a promoter of the company, in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The declaration confirmed that no other encumbrances were created by the promoters or promoter group members during the financial year ended March 31, 2026.

powered bylight_fuzz_icon
44498547

*this image is generated using AI for illustrative purposes only.

Aarti Drugs Limited disclosed that two members of its promoter group have encumbered a total of 12,39,771 shares as on March 31, 2026. The filing was submitted to the stock exchanges by Harshit M. Savla, a promoter of the company, in compliance with regulatory requirements.

Mirik Rajendra Gogri encumbered 6,41,814 shares, while Renil Rajendra Gogri encumbered 5,97,957 shares. The declaration confirms that apart from these specific instances, no other encumbrances were created by the promoters or promoter group members during the financial year ended March 31, 2026.

The disclosure was made under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters to report any encumbrance of shares to ensure transparency for shareholders.

Promoter and Promoter Group Structure

The filing included an annexure listing the complete structure of the promoter and promoter group entities associated with Aarti Drugs . The list comprises 42 entities, including individuals and corporate bodies.

Sr. No. Name Type (Category)
1 Prakash Moreshwar Patil Promoter
2 Harshit Manilal Savla Promoter
3 Rashesh Chandrakant Gogri Promoter Group
4 Priti Prakash Patil Promoter Group
5 Seema Harshit Savla Promoter Group
6 Hetal Gogri Gala Promoter Group
7 Chandrakant Vallabhaji Gogri Promoter
8 Jaya Chandrakant Gogri Promoter Group
9 Adhish P. Patil Promoter Group
10 Bhoomi Harshit Savla Promoter Group
11 Vishwa Harshit Savla Promoter Group
12 Aashay Rashesh Gogri Promoter Group
13 Mirik Rajendra Gogri Promoter Group
14 Renil Rajendra Gogri Promoter Group
15 Jigna Hiren Shah Promoter Group
16 Jay Manilal Savla Promoter Group
17 Indira Madan Dedhia Promoter Group
18 Manisha Rashesh Gogri Promoter Group
19 Aarnav Rashesh Gogri Promoter Group
20 Arati Tushar Sankhe Promoter Group
21 Prakash M. Patil (HUF) (Karta - Prakash Moreshwar Patil) Promoter Group
22 Arti Rajendra Gogri Promoter
23 Rajendra Vallabhaji Gogri Promoter
24 Arun Moreshwar Patil Promoter Group
25 Uday Moreshwar Patil Promoter Group
26 Vikas Moreshwar Patil Promoter Group
27 Kalika Amit Mishra Promoter Group
28 Hriman Savla Promoter Group
29 Kenisha Savla Promoter Group
30 Harshit M. Savla (HUF) (Karta - Harshit Manilal Savla) Promoter Group
31 Aashyav Business Trust (Alabhya Trusteeship Private Limited) Promoter Group
32 Tulip Family Trust (Gloire Trusteeship Services Private Limited) Promoter Group
33 Orchid Family Trust (Relacion Trusteeship Services Private Limited) Promoter Group
34 Paridhi Business Trust (Saswat Trusteeship Private Limited) Promoter Group
35 Gogri Finserv Pvt. Ltd. Promoter Group
36 Anushakti Enterprise Private Limited Promoter Group
37 Alchemie Finserv Pvt. Ltd. Promoter Group
38 Safechem Enterprises Private Limited Promoter Group
39 Dilesh Roadlines Pvt Ltd Promoter Group
40 Alchemie Financial Services Limited Promoter Group
41 Aarti Life Science LLP Promoter Group
42 Aarti Industries Limited Promoter Group

Historical Stock Returns for Aarti Drugs

1 Day5 Days1 Month6 Months1 Year5 Years
+3.99%+8.47%+12.39%+7.94%-12.24%-40.79%

What is the specific purpose for which the encumbered shares have been pledged by the promoter group members?

How might this encumbrance impact the promoter group's net worth and future ability to raise capital for the company?

Does the company anticipate any changes in its credit ratings or borrowing costs following this disclosure?

Aarti Drugs promoter group reduces stake by 1.67% via market sale

1 min read     Updated on 27 Jun 2026, 04:43 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Aarti Drugs Limited's promoter group reduced its shareholding by 1.67% via market sales and buyback between May 2024 and June 2026. The group disposed of a net total of 2,265,795 shares, bringing their total holding down to 54.43%. The company's equity capital also contracted due to a buyback of 665,000 shares in September 2024.

powered bylight_fuzz_icon
44104410

*this image is generated using AI for illustrative purposes only.

The promoter group of Aarti Drugs Limited has reduced its stake in the company by 1.67% through a series of market sales and buyback transactions between May 29, 2024, and June 24, 2026. The disclosure, submitted pursuant to Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, details the changes in shareholding by Dilesh Roadlines Private Limited and other members of the promoter group. The total equity share capital of the company decreased from 91,935,000 to 91,270,000 shares following a buyback of 665,000 shares in September 2024.

Shareholding Changes

The transactions resulted in a net disposal of 2,265,795 shares by the promoter group. Dilesh Roadlines Private Limited sold 125,998 shares, while other promoters disposed of 1,769,641 shares. Conversely, the group purchased 370,156 shares through market mechanisms during the specified period. The total promoter and promoter group holding, which previously stood at 55.70%, has now adjusted to 54.43% of the total paid-up capital.

Breakdown of Transactions

The following table summarizes the shareholding changes for the promoter group:

Entity Holding Before (Shares) Buyback/Sales (Shares) Purchase (Shares) Holding After (Shares) % After
Dilesh Roadlines Private Limited 492,545 -125,998 0 366,547 0.40
Other Promoters & Promoter Group 50,714,166 -1,769,641 370,156 49,314,681 54.03
Total 51,206,711 -1,895,639 370,156 49,681,228 54.43

Regulatory Context

The filing was made to the National Stock Exchange of India Limited and BSE Limited to comply with disclosure requirements regarding substantial acquisition and disposal of shares. The reduction in stake is attributed to market sales and the company's buyback program. The diluted share capital used for percentage calculations remained consistent with the equity share capital post-buyback, as there were no outstanding convertible securities or warrants.

Historical Stock Returns for Aarti Drugs

1 Day5 Days1 Month6 Months1 Year5 Years
+3.99%+8.47%+12.39%+7.94%-12.24%-40.79%

What are the strategic reasons behind the promoter group's decision to reduce their stake at this time?

How will the reduction in promoter holding influence Aarti Drugs' future governance and strategic decision-making?

Is the promoter group likely to continue divesting their stake in the coming quarters?

More News on Aarti Drugs

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-12.24%